Leede still bullish on Theratechnologies following "soft" quarter
After what he calls a “soft” first quarter, Leede Jones Gable analyst Doug Loe has maintained his “Speculative Buy” rating on Theratechnologies
Source: cantechletter.com
Doug Loe News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Doug Loe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Doug Loe Today - Breaking & Trending Today
CRRX will benefit from Ontario's decision, Leede says
A change in policy from the Ontario government is a positive for CareRx , says Leede Jones Gable analyst Doug Loe.
Source: cantechletter.com
EXE stock wins price target raise at Leede Jones Gable
Its fourth quarter results are in the books and Leede Jones Gable analyst Doug Loe is feeling more bullish about Extendicare
Source: cantechletter.com
Cipher Pharmaceuticals Inc. (CPHRF) CEO Craig Mull on Q2 2022 Results - Earnings Call Transcript
Cipher Pharmaceuticals Inc. (OTCPK:CPHRF) Q2 2022 Earnings Conference Call August 12, 2022, 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille -...
Source: seekingalpha.com
/cloudfront-us-east-1.images.arcpublishing.com/tgam/V4VDCIFHVVDNFLHNED5RNA75XM.JPG)
Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated
The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Geoff Robins/The Globe and Mail A tiny London, Ont., medical device company hoping to change how diabetes is treated has had a wild ride of late. Last Friday, stock in Sernova Corp. shot up 65 per cent on the TSX Venture Exchange, then nearly doubled on Monday, closing at $2.42 a share. At its peak, Sernova had a market capitali...
Source: theglobeandmail.com